AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Mar 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-03-07

Reporting Person: Do Hung (Sr Vice President Discovery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-07	Common stock	D	68418	$2.32	Disposed	1331361	Direct
2014-03-10	Common stock	D	108018	$2.28	Disposed	1223343	Direct
2014-03-11	Common stock	D	121642	$2.22	Disposed	1101701	Direct

Footnotes

F1: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $2.30 to $2.42. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $2.25 to $2.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $2.20 to $2.28. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.